Cough Expectorent Salbutamol (Salbutamol 2 mg + 216 333 Syrup GH CHC PHC OPD 2 mg + Bromhexine Bromhexine 4 mg 4 mg) 100 Inhalation – 334 GH CHC PHC OPD aerosol dose 217 335 Salbutamol Suspension 2 mg/5 ml GH CHC PHC OPD Nebulizer 336 solution 5 mg/ ml GH CHC PHC IPD (sulphate) Inhalation 218 337 + GH OPD (MDI) Salbutamol 115 mg + 35 338 Tablet GH CHC PHC OPD mg, Etophylline 231 mg + 69 339 + Tablet GH CHC PHC OPD 219 mg 169.4 mg + 340 Injection 56.6 mg/2 GH CHC PHC IPD ml Nebulizer 220 341 15 ml vial GH CHC IPD Budesonide solution Tablet 342 2 mg GH CHC PHC OPD (sulphate) 221 Salbutamol Tablet 343 4 mg GH CHC PHC OPD (sulphate) 24. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID-BASE DISTURBANCES 24.1 Parenteral Injectable Sub 344 5%, isotonic GH CHC PHC IPD solution centre 222 Injectable 10% 345 GH IPD solution isotonic 346 Injectable 25% GH IPD Glucose 5% glucose with Injectable + 0.9% 223 347 sodium GH CHC PHC IPD solution sodium chloride 224 348 Isolyte – P Injection GH CHC PHC IPD 225 349 Potassium Injectable 11.2% in GH IPD
216 333 Cough Expectorent (Salbutamol 2 mg + Bromhexine 4 mg) Syrup Salbutamol 2 mg + Bromhexine 4 mg GH CHC PHC OPD 217 334 Salbutamol Inhalation – aerosol 100 dose GH CHC PHC OPD 335 Suspension 2 mg/5 ml GH CHC PHC OPD 336 Nebulizer solution (sulphate) 5 mg/ ml GH CHC PHC IPD 218 337 + Salbutamol Inhalation (MDI) GH OPD 219 338 Etophylline + Tablet 115 mg + 35 mg, GH CHC PHC OPD 339 Tablet 231 mg + 69 mg GH CHC PHC OPD 340 Injection 169.4 mg + 56.6 mg/2 ml GH CHC PHC IPD 220 341 Budesonide Nebulizer solution 15 ml vial GH CHC IPD 221 342 Salbutamol Tablet (sulphate) 2 mg GH CHC PHC OPD 343 Tablet (sulphate) 4 mg GH CHC PHC OPD 24. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID-BASE DISTURBANCES 24.1 Parenteral 222 344 Injectable solution 5%, isotonic GH CHC PHC Sub centre IPD 345 Injectable solution 10% isotonic GH IPD 346 Injectable 25% GH IPD 223 347 Glucose with sodium Injectable solution 5% glucose + 0.9% sodium chloride GH CHC PHC IPD 224 348 Isolyte – P Injection GH CHC PHC IPD 225 349 Potassium Injectable 11.2% in GH IPD
Guidelines_for_purchases_under_Consolidated_User_Fee_Fund.docx